|
GB2213058B
(en)
*
|
1987-12-03 |
1991-07-17 |
Reckitt & Colmann Prod Ltd |
Compositions comprising buprenorphine and naltrexone for treatment of opiate addicts
|
|
GB8728294D0
(en)
*
|
1987-12-03 |
1988-01-06 |
Reckitt & Colmann Prod Ltd |
Treatment compositions
|
|
US5236714A
(en)
*
|
1988-11-01 |
1993-08-17 |
Alza Corporation |
Abusable substance dosage form having reduced abuse potential
|
|
US5272149A
(en)
*
|
1992-05-05 |
1993-12-21 |
Stalling Reginald W |
Symptom controlled receptor substitution for addiction withdrawl
|
|
US5512578A
(en)
*
|
1992-09-21 |
1996-04-30 |
Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University |
Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by exogenous and endogenous opiod agonists
|
|
US6096756A
(en)
|
1992-09-21 |
2000-08-01 |
Albert Einstein College Of Medicine Of Yeshiva University |
Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists
|
|
DE19652188C2
(de)
*
|
1996-12-16 |
2002-02-14 |
Lohmann Therapie Syst Lts |
Flache Arzneizubereitung zur Applikation und Freisetzung von Buprenorphin oder einer pharmakologisch vergleichbaren Substanz in der Mundhöhle und Verfahren zu ihrer Herstellung
|
|
US5968547A
(en)
*
|
1997-02-24 |
1999-10-19 |
Euro-Celtique, S.A. |
Method of providing sustained analgesia with buprenorphine
|
|
US7220737B1
(en)
|
1997-09-04 |
2007-05-22 |
Novoneuron, Inc |
Noribogaine in the treatment of pain and drug addiction
|
|
ES2224430T3
(es)
*
|
1997-09-04 |
2005-03-01 |
Novoneuron Inc |
Noribogaina en el tratamiento del dolor y de la toxicomania.
|
|
CN1204890C
(zh)
*
|
1997-12-22 |
2005-06-08 |
欧罗赛铁克股份有限公司 |
防止阿片样物质滥用的方法
|
|
US6375957B1
(en)
|
1997-12-22 |
2002-04-23 |
Euro-Celtique, S.A. |
Opioid agonist/opioid antagonist/acetaminophen combinations
|
|
TR200001942T2
(tr)
|
1997-12-22 |
2000-11-21 |
Euro-Celtique, S.A. |
Opioid agonist/antagonist kombinasyonlar
|
|
EP0984276A4
(en)
*
|
1998-02-16 |
2003-08-27 |
Inst Physical & Chem Res |
CAPILLARY CASSETTE AND METHOD FOR THE PRODUCTION THEREOF
|
|
US6007841A
(en)
*
|
1998-03-13 |
1999-12-28 |
Algos Pharmaceutical Corporation |
Analgesic composition and method for treating pain
|
|
US7087215B2
(en)
*
|
1998-12-21 |
2006-08-08 |
Generex Pharmaceuticals Incorporated |
Methods of administering and enhancing absorption of pharmaceutical agents
|
|
US6849263B2
(en)
*
|
1998-12-21 |
2005-02-01 |
Generex Pharmaceutical Incorporated |
Pharmaceutical compositions for buccal delivery of pain relief medications
|
|
CA2382577C
(en)
*
|
1999-08-27 |
2008-01-22 |
Southern Research Institute |
Injectable buprenorphine microparticle compositions and their use
|
|
RU2147880C1
(ru)
*
|
1999-11-10 |
2000-04-27 |
Мамренко Валерий Русланович |
Лекарственное средство для лечения пациентов с хроническим алкоголизмом и способ их лечения
|
|
AR031682A1
(es)
*
|
1999-11-19 |
2003-10-01 |
Reckitt Benckiser Helthcare Uk |
Composiciones farmaceuticas
|
|
SI2283842T1
(sl)
*
|
2000-02-08 |
2015-07-31 |
Euro-Celtique S.A. |
Oralne formulacije opioidnih agonistov, varne pred zlorabo
|
|
US6716449B2
(en)
|
2000-02-08 |
2004-04-06 |
Euro-Celtique S.A. |
Controlled-release compositions containing opioid agonist and antagonist
|
|
EP1387673B1
(en)
|
2001-05-11 |
2010-12-29 |
Endo Pharmaceuticals Inc. |
Abuse-resistant controlled-release opioid dosage form
|
|
US20030035839A1
(en)
*
|
2001-05-15 |
2003-02-20 |
Peirce Management, Llc |
Pharmaceutical composition for both intraoral and oral administration
|
|
WO2002098422A1
(en)
*
|
2001-06-05 |
2002-12-12 |
University Of Chicago |
Use of methylnaltrexone to treat immune suppression
|
|
DK1404331T3
(da)
*
|
2001-07-06 |
2008-01-28 |
Penwest Pharmaceuticals Co |
Sustained release-formuleringer af oxymorphon
|
|
US8329216B2
(en)
*
|
2001-07-06 |
2012-12-11 |
Endo Pharmaceuticals Inc. |
Oxymorphone controlled release formulations
|
|
KR20030034171A
(ko)
*
|
2001-07-06 |
2003-05-01 |
엔도 파마슈티걸즈, 인크. |
옥시모르폰 제어 방출 제형
|
|
DK1416842T3
(da)
*
|
2001-07-18 |
2009-03-16 |
Euro Celtique Sa |
Farmaceutiske kombinationer af oxycodon og naloxon
|
|
US20030068375A1
(en)
|
2001-08-06 |
2003-04-10 |
Curtis Wright |
Pharmaceutical formulation containing gelling agent
|
|
US20030044458A1
(en)
*
|
2001-08-06 |
2003-03-06 |
Curtis Wright |
Oral dosage form comprising a therapeutic agent and an adverse-effect agent
|
|
ES2326794T3
(es)
|
2001-08-06 |
2009-10-20 |
Euro-Celtique S.A. |
Formulaciones de agonistas opioides con antagonista liberable y secuestrado.
|
|
US20030157168A1
(en)
*
|
2001-08-06 |
2003-08-21 |
Christopher Breder |
Sequestered antagonist formulations
|
|
WO2003026743A2
(en)
*
|
2001-09-26 |
2003-04-03 |
Penwest Pharmaceuticals Company |
Opioid formulations having reduced potential for abuse
|
|
US6863901B2
(en)
*
|
2001-11-30 |
2005-03-08 |
Collegium Pharmaceutical, Inc. |
Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
|
|
US6827946B2
(en)
*
|
2001-12-05 |
2004-12-07 |
Collegium Pharmaceutical, Inc. |
Compositions containing both sedative and non-sedative antihistamines
|
|
LT2425821T
(lt)
|
2002-04-05 |
2017-07-25 |
Euro-Celtique S.A. |
Farmacinis preparatas, turintis oksikodono ir naloksono
|
|
PT2561860T
(pt)
*
|
2002-05-31 |
2018-05-08 |
Titan Pharmaceuticals Inc |
Dispositivo polimérico implantável para a libertação prolongada de buprenorfina
|
|
SI1551372T1
(en)
|
2002-09-20 |
2018-08-31 |
Alpharma Pharmaceuticals Llc |
SUBVENCATION DATA AND RELATED CONSTRUCTIONS AND PROCEDURES
|
|
MXPA05009757A
(es)
*
|
2003-03-13 |
2005-12-05 |
Controlled Chemicals Inc |
Conjugados de oxicodona con menor potencial de abuso y duracion de accion extendida.
|
|
SI1610791T1
(sl)
*
|
2003-03-31 |
2011-05-31 |
Titan Pharmaceuticals Inc |
Implantibilna polimerna naprava za zadržano sproščanje dopaminskega agonista
|
|
US20040202717A1
(en)
*
|
2003-04-08 |
2004-10-14 |
Mehta Atul M. |
Abuse-resistant oral dosage forms and method of use thereof
|
|
TWI347201B
(en)
|
2003-04-21 |
2011-08-21 |
Euro Celtique Sa |
Pharmaceutical products,uses thereof and methods for preparing the same
|
|
EP1604666A1
(en)
*
|
2004-06-08 |
2005-12-14 |
Euro-Celtique S.A. |
Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
|
|
ES2653568T3
(es)
|
2004-06-12 |
2018-02-07 |
Collegium Pharmaceutical, Inc. |
Formulaciones de fármacos para la prevención del abuso
|
|
EP1702558A1
(en)
*
|
2005-02-28 |
2006-09-20 |
Euro-Celtique S.A. |
Method and device for the assessment of bowel function
|
|
US7568409B2
(en)
*
|
2005-03-30 |
2009-08-04 |
Federal-Mogul World Wide, Inc |
Hybrid orbiting spindle for shaping non-circular holes
|
|
ZA200807571B
(en)
|
2006-03-01 |
2009-08-26 |
Ethypharm Sa |
Crush-resistant tablets intended to prevent accidental misuse and unlawful diversion
|
|
US20070212414A1
(en)
*
|
2006-03-08 |
2007-09-13 |
Penwest Pharmaceuticals Co. |
Ethanol-resistant sustained release formulations
|
|
SI2484346T1
(sl)
|
2006-06-19 |
2017-05-31 |
Alpharma Pharmaceuticals Llc |
Farmacevtski sestavki
|
|
EP1897543A1
(en)
*
|
2006-08-30 |
2008-03-12 |
Euro-Celtique S.A. |
Buprenorphine- wafer for drug substitution therapy
|
|
US8470361B2
(en)
|
2006-12-04 |
2013-06-25 |
Orexo Ab |
Non-abusable pharmaceutical composition comprising opioids
|
|
US20080199407A1
(en)
|
2007-02-15 |
2008-08-21 |
Slater Kenneth C |
Drug Detoxification Protocol Using Microdosing
|
|
EP2120945A1
(en)
*
|
2007-02-28 |
2009-11-25 |
Collegium Pharmaceutical, Inc. |
Antihistamine combination
|
|
GB2447014A
(en)
|
2007-03-01 |
2008-09-03 |
Reckitt Benckiser Healthcare |
Analgesic composition comprising a specific ratio of buprenorphine and naltrexone
|
|
US20090124650A1
(en)
*
|
2007-06-21 |
2009-05-14 |
Endo Pharmaceuticals, Inc. |
Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instructions on Effects of Alcohol
|
|
US20100151014A1
(en)
*
|
2008-12-16 |
2010-06-17 |
Alpharma Pharmaceuticals, Llc |
Pharmaceutical composition
|
|
US8623418B2
(en)
*
|
2007-12-17 |
2014-01-07 |
Alpharma Pharmaceuticals Llc |
Pharmaceutical composition
|
|
US20100266645A1
(en)
*
|
2007-12-17 |
2010-10-21 |
Alfred Liang |
Pharmaceutical compositions
|
|
SI2317991T1
(sl)
*
|
2008-07-07 |
2017-09-29 |
Euro-Celtique S.A. |
Uporaba opioidnih antagonistov za zdravljenje retencije urina
|
|
PL2405915T3
(pl)
|
2009-03-10 |
2019-05-31 |
Euro Celtique Sa |
Kompozycje farmaceutyczne o natychmiastowym uwalnianiu zawierające oksykodon i nalokson
|
|
US8475832B2
(en)
|
2009-08-07 |
2013-07-02 |
Rb Pharmaceuticals Limited |
Sublingual and buccal film compositions
|
|
US10668060B2
(en)
|
2009-12-10 |
2020-06-02 |
Collegium Pharmaceutical, Inc. |
Tamper-resistant pharmaceutical compositions of opioids and other drugs
|
|
US8765737B1
(en)
|
2010-05-11 |
2014-07-01 |
Demerx, Inc. |
Methods and compositions for preparing and purifying noribogaine
|
|
US9394294B2
(en)
|
2010-05-11 |
2016-07-19 |
Demerx, Inc. |
Methods and compositions for preparing and purifying noribogaine
|
|
US8362007B1
(en)
|
2010-05-11 |
2013-01-29 |
Demerx, Inc. |
Substituted noribogaine
|
|
US8802832B2
(en)
|
2010-06-22 |
2014-08-12 |
Demerx, Inc. |
Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
|
|
US8637648B1
(en)
|
2010-06-22 |
2014-01-28 |
Demerx, Inc. |
Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
|
|
US9586954B2
(en)
|
2010-06-22 |
2017-03-07 |
Demerx, Inc. |
N-substituted noribogaine prodrugs
|
|
US8741891B1
(en)
|
2010-06-22 |
2014-06-03 |
Demerx, Inc. |
N-substituted noribogaine prodrugs
|
|
CA2806232A1
(en)
|
2010-07-23 |
2012-01-26 |
Demerx, Inc. |
Noribogaine compositions
|
|
EP2481740B1
(en)
|
2011-01-26 |
2015-11-04 |
DemeRx, Inc. |
Methods and compositions for preparing noribogaine from voacangine
|
|
US9617274B1
(en)
|
2011-08-26 |
2017-04-11 |
Demerx, Inc. |
Synthetic noribogaine
|
|
ME02153B
(me)
|
2011-09-19 |
2015-10-20 |
Orexo Ab |
Nove farmaceutske kompozicije, otporne na zloupotrebu, za tretman zavisnosti od opioida
|
|
WO2013085922A1
(en)
|
2011-12-09 |
2013-06-13 |
Demerx, Inc. |
Phosphate esters of noribogaine
|
|
US9211293B2
(en)
*
|
2011-12-15 |
2015-12-15 |
Alkermes Pharma Ireland Limited |
Opioid agonist antagonist combinations
|
|
US9150584B2
(en)
|
2012-01-25 |
2015-10-06 |
Demerx, Inc. |
Indole and benzofuran fused isoquinuclidene derivatives and processes for preparing them
|
|
WO2013112673A1
(en)
|
2012-01-25 |
2013-08-01 |
Demerx, Inc. |
Synthetic voacangine
|
|
EP2934541A4
(en)
|
2012-12-20 |
2016-08-03 |
Demerx Inc |
SUBSTITUTED NORIBOGAIN
|
|
US9045481B2
(en)
|
2012-12-20 |
2015-06-02 |
Demerx, Inc. |
Substituted noribogaine
|
|
KR20160034352A
(ko)
|
2013-07-23 |
2016-03-29 |
유로-셀티큐 에스.에이. |
장내 세균총이상을 초래하고/하거나 장내 박테리아 전위에 대한 위험을 증가시키는 질환과 통증으로 인해 고통받고 있는 환자에서 통증을 치료하는데 사용하기 위한 옥시코돈과 날록손의 조합물
|
|
US9550789B2
(en)
|
2014-06-18 |
2017-01-24 |
Demerx, Inc. |
Halogenated indole and benzofuran derivatives of isoquinuclidene and processes for preparing them
|
|
CA2998147A1
(en)
*
|
2015-09-09 |
2017-03-16 |
Biodelivery Sciences International, Inc. |
Methods of safely transitioning a subject to buprenorphine
|
|
US9737530B1
(en)
|
2016-06-23 |
2017-08-22 |
Collegium Pharmaceutical, Inc. |
Process of making stable abuse-deterrent oral formulations
|
|
ES3064839T3
(en)
|
2017-11-15 |
2026-04-29 |
Univ California |
Combination of cannabidiol and buprenorphine and its use for the treatment of chronic pain
|